BiotechTube
Home/Immuneering/Harold 'E.B.' Brakewood
H'

Harold 'E.B.' Brakewood

Chief Business Officer

Immuneering

Therapeutic Areas

Oncology

Immuneering Pipeline

DrugIndicationPhase
IMM-1-104Advanced solid tumors with MAPK pathway mutationsPhase 1/2a
IMM-6-415Undisclosed oncology targetDiscovery
Partnered Program AUndisclosed oncology targetNot Disclosed
Partnered Program BUndisclosed oncology targetNot Disclosed

Leadership Team at Immuneering

BZ
Ben Zeskind
Co-Founder, President, Chief Executive Officer, Director
MB
Michael Bookman
Chief Legal Officer, Secretary
BH
Brett Hall
Chief Scientific Officer
CA
Christian Alaia
Senior Director, Financial Planning & Analysis
NA
Naseem Alkaabi
Senior Research Associate
DA
Damaris Arcila
Senior Accountant
HA
Hemalatha Athawale
Senior Research Associate
View full Immuneering profile